Skip to Main Content

Author Details

Jing Tang
University of Helsinki
2007
70
32
PMIDPaper TitleJournal TitlePublished Year
37225408GraphscoreDTA: optimized graph neural network for protein-ligand binding affinity prediction.Bioinformatics2023
37041243Harmonizing across datasets to improve the transferability of drug combination prediction.Commun Biol2023
34472587Minimal information for chemosensitivity assays (MICHA): a next-generation pipeline to enable the FAIRification of drug screening experiments.Brief Bioinform2022
35440130Bipartite network models to design combination therapies in acute myeloid leukaemia.Nat Commun2022
35729494Using BERT to identify drug-target interactions from whole PubMed.BMC Bioinformatics2022
35389453The ENDS of assumptions: an online tool for the epistemic non-parametric drug-response scoring.Bioinformatics2022
36477604DrugRepo: a novel approach to repurposing drugs based on chemical and genomic features.Sci Rep2022
35106508A community challenge for a pancancer drug mechanism of action inference from perturbational profile data.Cell Rep Med2022
33040150Anticancer drug synergy prediction in understudied tissues using transfer learning.J Am Med Inform Assoc2021
33825201Drug synergy of combinatory treatment with remdesivir and the repurposed drugs fluoxetine and itraconazole effectively impairs SARS-CoV-2 infection in vitro.Br J Pharmacol2021
33834186Network-based modeling of herb combinations in traditional Chinese medicine.Brief Bioinform2021
33632781Identification of Celecoxib-Targeted Proteins Using Label-Free Thermal Proteome Profiling on Rat Hippocampus.Mol Pharmacol2021
34575474Combination Therapy with Fluoxetine and the Nucleoside Analog GS-441524 Exerts Synergistic Antiviral Effects against Different SARS-CoV-2 Variants In Vitro.Pharmaceutics2021
34848761Drug repurposing for COVID-19 using graph neural network and harmonizing multiple evidence.Sci Rep2021
34478517Heterogeneous modulation of Bcl-2 family members and drug efflux mediate MCL-1 inhibitor resistance in multiple myeloma.Blood Adv2021
34343245Network-guided identification of cancer-selective combinatorial therapies in ovarian cancer.Brief Bioinform2021
34060634DrugComb update: a more comprehensive drug sensitivity data repository and analysis portal.Nucleic Acids Res2021
32055842Exploration of databases and methods supporting drug repurposing: a comprehensive survey.Brief Bioinform2021
33361461Seasonal Variation in the Brain μ-Opioid Receptor Availability.J Neurosci2021
33300000Minimal information for Chemosensitivity assays (MICHA): A next-generation pipeline to enable the FAIRification of drug screening experiments.bioRxiv2021
31439679Multi-parametric single cell evaluation defines distinct drug responses in healthy hematologic cells that are retained in corresponding malignant cell types.Haematologica2020
31901864Corrigendum to 'Combined gene essentiality scoring improves the prediction of cancer dependency maps' [EBioMedicine 50 (2019) 66-79].EBioMedicine2020
33330858Drug Repurposing for COVID-19 using Graph Neural Network with Genetic, Mechanistic, and Epidemiological Validation.Res Sq2020
33101394Chloroplot: An Online Program for the Versatile Plotting of Organelle Genomes.Front Genet2020
32982738Unsupervised Learning and Multipartite Network Models: A Promising Approach for Understanding Traditional Medicine.Front Pharmacol2020
32118251SynergyFinder: a web application for analyzing drug combination dose-response matrix data.Bioinformatics2020
32503292Can We Assume the Gene Expression Profile as a Proxy for Signaling Network Activity?Biomolecules2020
30452546Loss-of-function mutations with circadian rhythm regulator Per1/Per2 lead to premature ovarian insufficiencyâ¿ .Biol Reprod2019
31732481Combined gene essentiality scoring improves the prediction of cancer dependency maps.EBioMedicine2019
31765369Predicting Meridian in Chinese traditional medicine using machine learning approaches.PLoS Comput Biol2019
31312514Network pharmacology modeling identifies synergistic Aurora B and ZAK interaction in triple-negative breast cancer.NPJ Syst Biol Appl2019
30837884Making Sense of the Epigenome Using Data Integration Approaches.Front Pharmacol2019
31066443DrugComb: an integrative cancer drug combination data portal.Nucleic Acids Res2019
31107860Drug combination sensitivity scoring facilitates the discovery of synergistic and efficacious drug combinations in cancer.PLoS Comput Biol2019
28804127Discovery of novel drug sensitivities in T-PLL by high-throughput ex vivo drug testing and mutation profiling.Leukemia2018
30219839Drug Target Commons 2.0: a community platform for systematic analysis of drug-target interaction profiles.Database (Oxford)2018
29483097Patient-Customized Drug Combination Prediction and Testing for T-cell Prolymphocytic Leukemia Patients.Cancer Res2018
29276046Drug Target Commons: A Community Effort to Build a Consensus Knowledge Base for Drug-Target Interactions.Cell Chem Biol2018
29344898Methods for High-throughput Drug Combination Screening and Synergy Scoring.Methods Mol Biol2018
28619982JAK1/2 and BCL2 inhibitors synergize to counteract bone marrow stromal cell-induced protection of AML.Blood2017
29991977Corrigendum to "Searching for drug synergy in complex dose-response landscapes using an interaction potency model" [Comput. Struct. Biotechnol. J. 13 (2015) 504-513].Comput Struct Biotechnol J2017
28104295Systematic drug sensitivity testing reveals synergistic growth inhibition by dasatinib or mTOR inhibitors with paclitaxel in ovarian granulosa cell tumor cells.Gynecol Oncol2017
28379339SynergyFinder: a web application for analyzing drug combination dose-response matrix data.Bioinformatics2017
28322833Treatment of novel IL17A inhibitor in glioblastoma implementing 3rd generation co-culture cell line and patient-derived tumor model.Eur J Pharmacol2017
28988802A Community Challenge for Inferring Genetic Predictors of Gene Essentialities through Analysis of a Functional Screen of Cancer Cell Lines.Cell Syst2017
28730498Informatics Approaches for Predicting, Understanding, and Testing Cancer Drug Combinations.Methods Mol Biol2017
28569207Seed-effect modeling improves the consistency of genome-wide loss-of-function screens and identifies synthetic lethal vulnerabilities in cancer cells.Genome Med2017
27721464Erratum: Crowdsourced assessment of common genetic contribution to predicting anti-TNF treatment response in rheumatoid arthritis.Nat Commun2016
24723570Toward more realistic drug-target interaction predictions.Brief Bioinform2015
26388771What is synergy? The Saariselkä agreement revisited.Front Pharmacol2015
  • 1 - 50 of 70

Recommended Authors

Lang Li
College of Medicine, The Ohio State University
Career Start Year 2018
Number of shared co-authors 1
??smund Flobak
Norwegian University of Science and Technology
Career Start Year 2015
Number of shared co-authors 2
Neel S Madhukar
Weill Cornell Medical College
Career Start Year 2015
Number of shared co-authors 1
Minji Jeon
Korea University College of Medicine
Career Start Year 2014
Number of shared co-authors 9
Wail Ba-Alawi
Princess Margaret Cancer Centre, University Health Network, University Ave.
Career Start Year 2013
Number of shared co-authors 1
Hua Xu
The University of Texas Health Science Center at Houston
Career Start Year 2012
Number of shared co-authors 2
Kelly Regan
The Children's Hospital of Philadelphia
Career Start Year 2012
Number of shared co-authors 0
Nehme El-Hachem
Centre Hospitalier Universitaire Sainte-Justine Research Centre
Career Start Year 2011
Number of shared co-authors 1
Minjae Yoo
University of Colorado Anschutz Medical Campus
Career Start Year 2011
Number of shared co-authors 0
Bin Chen
Jiangsu University
Career Start Year 2009
Number of shared co-authors 0
Woochang Hwang
College of Medicine, Hanyang University
Career Start Year 2006
Number of shared co-authors 0
Ola Spjuth
Department of Pharmaceutical Biosciences, Uppsala University
Career Start Year 2006
Number of shared co-authors 1
James C Costello
University of Colorado Anschutz Medical Campus
Career Start Year 2006
Number of shared co-authors 23
Rajarshi Guha
Vertex Pharmaceuticals
Career Start Year 2004
Number of shared co-authors 6
Holger Fr??hlich
Bonn-Aachen International Center for IT (B-IT), University of Bonn
Career Start Year 2004
Number of shared co-authors 11
Doheon Lee
Korea Advanced Institute of Science and Technology
Career Start Year 2004
Number of shared co-authors 0
Benjamin Haibe-Kains
Princess Margaret Cancer Centre, University Health Network
Career Start Year 2004
Number of shared co-authors 4
Aik Choon Tan
Huntsman Cancer Institute, The University of Utah
Career Start Year 2003
Number of shared co-authors 2
Anang A Shelat
St. Jude Children's Research Hospital
Career Start Year 2003
Number of shared co-authors 1
Bairong Shen
Institute for Systems Genetics, Western China Hospital, Sichuan University
Career Start Year 2003
Number of shared co-authors 2
Assaf Gottlieb
Center for Precision Health, University of Texas Health Science Center at Houston
Career Start Year 2002
Number of shared co-authors 5
Lang Li
Harbin Medical University
Career Start Year 2002
Number of shared co-authors 1
J??rg Rahnenf??hrer
TU Dortmund University
Career Start Year 2002
Number of shared co-authors 1
Sunkyu Kim
Korea University
Career Start Year 2000
Number of shared co-authors 9
Ranadip Pal
Texas Tech University
Career Start Year 1999
Number of shared co-authors 0
Stephan C Sch??rer
Institute for Data Science and Computing, University of Miami
Career Start Year 1998
Number of shared co-authors 4
Bissan Al-Lazikani
The University of Texas MD Anderson Cancer Center
Career Start Year 1997
Number of shared co-authors 3
Cristian G Bologa
University of New Mexico School of Medicine
Career Start Year 1995
Number of shared co-authors 3
Tudor I Oprea
Expert Systems Inc.
Career Start Year 1993
Number of shared co-authors 8
Weida Tong
National Center for Toxicological Research
Career Start Year 1992
Number of shared co-authors 1

Collaborators

Tero Aittokallio
Institute for Molecular Medicine Finland (FIMM), University of Helsinki
Co-authored papers 25
Krister Wennerberg
University of Copenhagen
Co-authored papers 25
Yinyin Wang
University of Helsinki
Co-authored papers 10
Shuyu Zheng
University of Helsinki
Co-authored papers 9
Peddinti Gopalacharyulu
Technical Research Centre of Finland
Co-authored papers 6
Alok Jaiswal
Indian Institute of Technology Kanpur
Co-authored papers 6
Suleiman A Khan
Helsinki Institute for Information Technology (HIIT), Aalto University
Co-authored papers 5
Matej Ore??i??
University of Turku and Abo Akademi University
Co-authored papers 5
Olli Kallioniemi
Karolinska Institute
Co-authored papers 4
Mohieddin Jafari
Co-authored papers 3
Yejin Kim
University of Texas Health Science Center at Houston
Co-authored papers 3
Yuanfang Guan
University of Michigan ann arbor
Co-authored papers 3
Xiaoqian Jiang
Carnegie Mellon University, The University of Texas Health Science Center at Houston, University of California San Diego
Co-authored papers 3
Guanghua Xiao
The University of Texas Southwestern Medical Center
Co-authored papers 2
Luyao Chen
University of Texas Health Science Center at Houston
Co-authored papers 2
Zhongming Zhao
Center for Precision Health, The University of Texas Health Science Center at Houston
Co-authored papers 2
Bruce Hoff
Hughes Research Laboratories
Co-authored papers 2
Jaakko Kaprio
Co-authored papers 2
Min Shen
National Center for Advancing Translational Sciences, National Institutes of Health
Co-authored papers 2
Julio Saez-Rodriguez
Institute of Computational Biomedicine, Heidelberg University
Co-authored papers 2
Yang Xie
Quantitative Biomedical Research Center
Co-authored papers 2
Xiaowei Zhan
Southwestern Medical Center, University of Texas
Co-authored papers 2
Samuel Kaski
Aalto University
Co-authored papers 2
Kerstin Bunte
University of Groningen
Co-authored papers 2
Kanglin Hsieh
University of Texas Health Science Center at Houston
Co-authored papers 2
Tao Wang
University of Texas Southwestern Medical Center
Co-authored papers 2
Thea Norman
Bill & Melinda Gates Foundation
Co-authored papers 2
Tapio Pahikkala
University of Turku
Co-authored papers 2
Sean I Savitz
University of Texas Health Science Center at Houston
Co-authored papers 2
Gustavo Stolovitzky
IBM T.J. Watson Research Center
Co-authored papers 2
Release 1.2